Increased mutability to fosfomycin resistance in Proteus mirabilis clinical isolates

Autor(es)

Fonseca, Marina R. B. ^[1] ; Sato, Juliana L. ^[1] ; Lima-Noronha, Marco A. ^[1] ; Migliorini, Leticia B. ^[1] ; Fernandez-Silva, Frank S. ^[1] ; Galhardo, Rodrigo S. ^[1]

Afiliação do(s) autor(es)

^[1] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, SP - Brazil

• Tipo de documento: Artigo Científico
• Fonte: INFECTION GENETICS AND EVOLUTION; v. 58, p. 27-33, MAR 2018.
• Citações Web of Science: 0

Resumo

In the present study, we screened a collection of 77 Proteus mirabilis clinical isolates for the presence of mutators, using the frequency of both rifampicin and fosfomycin resistance mutants as markers of spontaneous mutagenesis. We found that none of the strains in our collection are mutators for the rifampicin resistance (Rif(R)) marker. Nevertheless, a significant fraction of the isolates (17%) show high frequencies of fosfomycin resistant mutants (Fos(R)). We show that this increased mutability to FosR correlates with a low level of resistance to Fosfomycin (MICs 8-64 mu g/ml). These strains also show high frequencies of single step mutants with clinically relevant FosR resistance levels (MIC >= 256 mu g/ml). Our findings point out to the risk of fosfomycin resistance emergence in P. mirabilis. (AU)

• Processo FAPESP: 15/11348-3 - Caracterização do fenótipo mutador de isolados de Proteus mirabilis
• Beneficiário: Marina Rocha Borges da Fonseca
• Modalidade de apoio: Bolsas no Brasil - Mestrado